Screener
AtriCure ATRC EBITDA
Discontinued — last reported Q2 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from AtriCure’s reported figures.
The source filing: AtriCure’s 10-Q, filed July 27, 2026. Open the filing →
- Filed
- Jul 27, 2026, 1:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001323885-26-000035
FAQ
- What is AtriCure's EBITDA?
- AtriCure (ATRC) reported EBITDA of $14.24M in Q2 2026.
- How has AtriCure's EBITDA changed year-over-year?
- AtriCure's EBITDA increased by 1494.5% year-over-year, from -$1.02M to $14.24M.
- What is the long-term trend for AtriCure's EBITDA?
- Over 2 years (2022 to 2024), AtriCure's EBITDA has grown at a -17.1% compound annual growth rate (CAGR), from -$30.96M to -$21.28M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about AtriCure's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude